cancer research at saficor
saficor  
Technology
Cancer Portal
Business
Employment
Contact
Home
 
HomeMechanismLab StudiesToxicityClinical Study

SAFINURTM (Cancer Research)

Mechanism of Action


Safinur completely stops cell growth/proliferation, cell movement and cell invasion. Because of this multiplicity of effects, we investigated whether Safinur was affecting a general cellular mechanism. The Safinur molecule has two active ends. One end helps the molecule enter the cancer cell through membrane transporters. Cancer cells upregulate these transporters allowing for the increased uptake of Safinur in a selective fashion. Once inside, the other end of the Safinur molecule irreversibly disrupts the cytoskeleton.

The cytoskeleton is a non-redundant biological structure, which is essential for cell survival. Cellular growth, morphology, mobility, invasiveness and nutrition are processes that are dependent on the cytoskeleton, which is common to all cells. It is an integral part of the cell contributing to all its physiological activity. To illustrate Safinur's disruption of the cytoskeleton, adherent breast carcinoma cells (MCF-7) grown on chamber slides were treated with Safinur for 2 h, fixed, and stained with a cytoskeleton specific primary monoclonal antibody. As shown in the accompanying figure in panel A, Safinur treatment dramatically disrupts the organization of cytoskleleton filaments within the cells. This disruption coincided with the 2-h time frame for cell disruption observed previously.  Panel B demonstrates that Safinur directly disrupted cytoskeletal filaments in a cell-free assay.  The nature and kinetics of the disruption is currently under investigation.

(A) Safinur disrupts cytoskeleton filaments. Immunofluorescence. Adherent MCF-7 cells were incubated for 2 h ± 0.01% Safinur. Cytoskeleton filaments were stained with a primary antibody and TRITC-anti-mouse IgG.

Control

Safinur-treated

(B) Purified cytoskeleton. cytoskeleton monomers (pre-incubated for 1 h ± 0.01% Safinur) was polymerized on a glass slide. Filaments were visualized with TRITC-phalloidin. Magnification:200X

Control

Safinur-treated

 


Educational corner: Examples of interrupted cell activities as a result of cytoskeleton disruption

Why is disrupting the cytoskeleton important in combating cancer cells? Cancer cells are highly mitotic, highly voracious and highly mobile and because all these activities are cytoskeleton dependent, its disruption is a major anti-tumor mechanism.

 
Example 1: The process of cytokinesis (division of cells) is dependent on the cytoskeleton. In the picture below, two cells in the process of dividing, bud-off with the help of a cytoskeletal contractile ring. This process is prevented from occurring in the presence of Safinur.

Example 2: One process by which cells uptake nutrients is that of phagocytosis and endocytosis. These processes are dependent on the reorganization of the cytoskeleton. By disrupting the cytoskleton, Safinur prevents the cell from uptaking nutrients.

Example 3: Cellular mobility is dependent on the reorganization of the cytoskeleton. Unlike our bone skeleton, which is relatively stable, the cytoskeleton is more dynamic, reorganizing in a relatively fast process. This process occurs by the tread milling of protein monomers into larger filaments necessary for cellular mobility. Safinur disrupts this tread milling process by chelating the monomers and preventing their uptake by the growing filaments (below).


If you have any questions regarding information contained in this website, please give us a call at 714-532-4632 or email us at info@safinur.com

 

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved

Disclaimer

 The information contained here is not intended as a substitute for medical professional help or advice but is to be used only for informational purposes. A physician should always be consulted for any health problem or medical condition. Safinur has not yet undergone organized clinical trials for cancer. It is provided as a dietary supplement for clinical study. Before taking this or other dietary supplements consult your physician. Safinur has been shown to be uniquely non-toxic in many animal studies; however, systematic human studies on toxicity have not been conducted. Statements made on this website have not been evaluated by the FDA and are not meant to diagnose, treat, cure or prevent any disease.

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved